Hanley stated that Nexsen has partnered with Atomo Diagnostics to manufacture the first 10,000 units of StrepSure, which will be used as part of the clinical trial. However, the company plans to seek third-party manufacturing and plans to control marketing distribution internally.
That's the kicker only a test wow. AT1 won't be the manufacture in the future. Test only.
- Forums
- ASX - By Stock
- AT1
- AT1 FY21 - General Discussion + FA
AT1 FY21 - General Discussion + FA, page-2432
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $13.42M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.0¢ | $8.115K | 394.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 650696 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 5440 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 650696 | 0.020 |
6 | 370742 | 0.019 |
6 | 505953 | 0.018 |
6 | 1035888 | 0.017 |
1 | 200001 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 5440 | 1 |
0.023 | 670706 | 2 |
0.024 | 270000 | 4 |
0.025 | 332555 | 3 |
0.026 | 995368 | 3 |
Last trade - 14.22pm 15/11/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online